nifedipine has been researched along with Atherosclerotic Parkinsonism in 4 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A similar dose-response relationship was determined for nifedipine, an L-type calcium channel antagonist." | 1.31 | Pharmacological involvement of the calcium channel blocker flunarizine in dopamine transmission at the striatum. ( Armando, I; Belforte, JE; Buño, W; Magariños-Azcone, C; Pazo, JH, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, U | 1 |
| Das, P | 1 |
| Gambhir, IS | 1 |
| Chakrabarti, SS | 1 |
| Haghdoost-Yazdi, H | 1 |
| Hosseini, SS | 1 |
| Faraji, A | 1 |
| Nahid, D | 1 |
| Jahanihashemi, H | 1 |
| Belforte, JE | 1 |
| Magariños-Azcone, C | 1 |
| Armando, I | 1 |
| Buño, W | 1 |
| Pazo, JH | 1 |
| Fernandez Pardal, M | 1 |
| Fernandez Pardal, J | 1 |
| Micheli, F | 1 |
4 other studies available for nifedipine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
L-type calcium channel blockers and a symptom complex mimicking de Melo-Souza's syndrome.
Topics: Aged; Amlodipine; Calcium Channel Blockers; Calcium Channels, L-Type; Diagnosis, Differential; Femal | 2019 |
Long term exposure to norharman exacerbates 6-hydroxydopamine-induced parkinsonism: possible involvement of L-type Ca2+ channels.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain; Calcium Channel Blockers; Calcium Channels, | 2010 |
Pharmacological involvement of the calcium channel blocker flunarizine in dopamine transmission at the striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Calcium Channel Blockers; Calcium Channels, L- | 2001 |
Aggravation of Parkinson's disease by cinnarizine.
Topics: Animals; Caudate Nucleus; Cinnarizine; Dopamine; Flunarizine; Male; Nifedipine; Parkinson Disease, S | 1988 |